Assessment of a High Sensitivity Method for Identification of

IDH1 mutation biomarker intrahepatic cholangiocarcinoma liquid biopsy qPCR

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
30 Mar 2019
Historique:
received: 11 03 2019
revised: 26 03 2019
accepted: 28 03 2019
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 3 4 2019
Statut: epublish

Résumé

Hotspot codon 132 mutations (R132x

Identifiants

pubmed: 30935002
pii: cancers11040454
doi: 10.3390/cancers11040454
pmc: PMC6521091
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Dig Liver Dis. 2010 Jul;42(7):490-5
pubmed: 20022823
Arch Surg. 2011 Jun;146(6):697-703
pubmed: 21690446
Oncologist. 2012;17(1):72-9
pubmed: 22180306
Hum Pathol. 2012 Oct;43(10):1552-8
pubmed: 22503487
Nat Genet. 2012 May 06;44(6):690-3
pubmed: 22561520
Oncogene. 2013 Jun 20;32(25):3091-100
pubmed: 22824796
Oncogene. 2013 Oct 10;32(41):4861-70
pubmed: 23318457
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Gastroenterology. 2013 Dec;145(6):1215-29
pubmed: 24140396
Nat Genet. 2013 Dec;45(12):1470-1473
pubmed: 24185509
Curr Opin Gastroenterol. 2014 May;30(3):295-302
pubmed: 24569570
Genes Chromosomes Cancer. 2014 Dec;53(12):1033-40
pubmed: 25231053
Cell Cycle. 2014;13(20):3176-82
pubmed: 25485496
Oncologist. 2015 Sep;20(9):1019-27
pubmed: 26245674
Clin Cancer Res. 2016 Jan 15;22(2):291-300
pubmed: 26405193
Clin Lab. 2016;62(4):689-96
pubmed: 27215089
J Gastrointest Oncol. 2016 Oct;7(5):797-803
pubmed: 27747093
Oncotarget. 2017 Jan 10;8(2):2329-2341
pubmed: 27911876
Therap Adv Gastroenterol. 2017 Jun;10(6):507-520
pubmed: 28567120
Cell Rep. 2017 Jun 27;19(13):2878-2880
pubmed: 28658632
Cancer Discov. 2017 Oct;7(10):1116-1135
pubmed: 28667006
Oncotarget. 2017 Jun 13;8(43):75627-75637
pubmed: 29088897
Expert Opin Emerg Drugs. 2018 Mar;23(1):63-75
pubmed: 29468924
Clin Cancer Res. 2018 Sep 1;24(17):4154-4161
pubmed: 29848569
BMC Genomics. 2018 Jun 5;19(1):440
pubmed: 29871612
Front Genet. 2018 Oct 23;9:493
pubmed: 30405699

Auteurs

Caterina Peraldo-Neia (C)

Cancer Genomics Laboratory, Fondazione Edo ed Elvo Tempia, Via Malta 3, 13900 Biella, Italy. caterina.peraldoneia@fondazionetempia.org.

Maria Scatolini (M)

Laboratory of Molecular Oncology, Fondazione Edo ed Elvo Tempia, Via dei Ponderanesi 2, 13875 Ponderano, Biella, Italy. maria.scatolini@fondazionetempia.org.

Enrico Grosso (E)

Laboratory of Molecular Oncology, Fondazione Edo ed Elvo Tempia, Via dei Ponderanesi 2, 13875 Ponderano, Biella, Italy. enrico.grosso@fondazionetempia.org.

Pasquale Lombardi (P)

Department of Oncology, University of Turin, 10100 Torino, Italy. pasquale.lombardi@unito.it.

Roberto Filippi (R)

Department of Oncology, University of Turin, 10100 Torino, Italy. roberto.filippi@unito.it.

Chiara Raggi (C)

Department of Experimental and Clinical Medicine, University of Firenze, 50100 Firenze, Italy. chiara.raggi@unifi.it.
Center for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, 20089 Rozzano, Italy. chiara.raggi@unifi.it.

Caterina Marchiò (C)

Department of Medical Sciences, University of Turin, 10100 Torino, Italy. caterina.marchio@ircc.it.
Pathology Unit, Candiolo Cancer Institute-FPO-IRCCS, Candiolo, 10060 Torino, Italy. caterina.marchio@ircc.it.

Giuliana Cavalloni (G)

Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060 Torino, Italy. giuliana.cavalloni@ircc.it.

Massimo Aglietta (M)

Department of Oncology, University of Turin, 10100 Torino, Italy. massimo.aglietta@ircc.it.
Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060 Torino, Italy. massimo.aglietta@ircc.it.

Francesco Leone (F)

Department of Oncology, University of Turin, 10100 Torino, Italy. francesco.leone@unito.it.
Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060 Torino, Italy. francesco.leone@unito.it.

Classifications MeSH